A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
NCT01672476 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 293
Last updated 2016-07-01
Summary
A Randomized, Double-Blind, Multicenter, phase III Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan (BR-A-657·K) 30mg Compared to Placebo in Patients with Mild to Moderate Essential Hypertension
Conditions
Interventions
- DRUG
-
Placebo
- DRUG
-
Valsartan
Valsartan 80mg
- DRUG
-
Fimasartan
Fimasartan 30mg
Sponsors & Collaborators
-
Bucheon St. Mary's Hospital
collaborator OTHER -
Konyang University Hospital
collaborator OTHER -
Korea University Anam Hospital
collaborator OTHER -
National Health Insurance Service Ilsan Hospital
collaborator OTHER -
Daegu Fatima Hospital
collaborator OTHER -
Dong-A University
collaborator OTHER -
Soon Chun Hyang University
collaborator OTHER -
Asan Medical Center
collaborator OTHER -
Gangnam Severance Hospital
collaborator OTHER -
Severance Hospital
collaborator OTHER -
Ulsan University Hospital
collaborator OTHER -
Kangbuk Samsung Hospital
collaborator OTHER -
Sejong General Hospital
collaborator OTHER -
Ewha Womans University Mokdong Hospital
collaborator OTHER -
Jeju National University Hospital
collaborator OTHER -
Hallym University Medical Center
collaborator OTHER -
Hanyang University
collaborator OTHER -
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
Seok Min Kang, M.D., Ph.D. · Severance Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-03-31
- Completion
- 2013-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
NCT00922480 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers
NCT00937534 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
NCT05878561 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
NCT02022774 ·Status: COMPLETED
-
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
NCT01135212 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
NCT01289886 ·Status: COMPLETED ·Phase: PHASE1
-
Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
NCT01289899 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
NCT02620306 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Fimasartan for Early Diastolic Heart Failure
NCT01691118 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
NCT02222480 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers
NCT01146938 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
NCT01148368 ·Status: COMPLETED ·Phase: PHASE1
-
Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
NCT00856271 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan
NCT02147704 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
NCT02394392 ·Status: COMPLETED
-
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
NCT03250052 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)
NCT02385721 ·Status: COMPLETED
-
Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
NCT00168779 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
NCT02407210 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
NCT00938132 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacovigilance and Patient Compliance in Hypertensive Patients
NCT02200575 ·Status: COMPLETED
-
Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension
NCT02466490 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
NCT02248961 ·Status: COMPLETED ·Phase: PHASE3
-
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
NCT02609490 ·Status: COMPLETED ·Phase: PHASE3